Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Orbimed Advisers Largest Holdings in 4th Quarter: 13F Alert

The following are Orbimed Advisors LLC top 10 holdings by market value as of December 31, according to a filing with the U.S. Securities and Exchange Commission on 02/14/2011.

Company Name                 Ticker      Market Value      Current     Change
                                            (USD $)       Position  In Position
Amgen Inc                    AMGN US      136,064,160    2,478,400     -383,100
Genzyme Corp                 GENZ US      134,126,560    1,883,800      251,200
Gilead Sciences Inc          GILD US      121,088,712    3,341,300       -5,500
Merck & Co. Inc.             MRK US       118,805,860    3,296,500      -10,000
Pfizer Inc                   PFE US       108,859,670    6,217,000   -2,755,000
Bristol-Myers Squibb Co      BMY US       104,754,880    3,956,000     -669,500
Biomarin Pharmaceutical Inc  BMRN US       91,817,835    3,409,500     -238,000
Shire Plc-ADR                SHPGY US      90,894,804    1,255,800      -89,600
Thermo Fisher Scientific Inc TMO US        84,363,104    1,523,900      208,500
Allergan Inc                 AGN US        80,227,161    1,168,300       81,800
 
SOURCE: SEC 13F-HR 
FILER: Orbimed Advisors LLC 
QUARTER ENDED: 12/31/2010 
SEC RECEIVED: 02/14/2011

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.